Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHA:600513)
China
· Delayed Price · Currency is CNY 22.61
+0.72 (3.29%)
Apr 30, 2026, 11:30 AM CST
SHA:600513 Revenue
In the year 2025, Jiangsu Lianhuan Pharmaceutical had annual revenue of 2.71B CNY with 25.52% growth. Jiangsu Lianhuan Pharmaceutical had revenue of 629.40M in the quarter ending December 31, 2025, with 22.01% growth.
Revenue
2.71B
Revenue Growth
+25.52%
P/S Ratio
2.30
Revenue / Employee
1.95M
Employees
1,388
Market Cap
6.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.71B | 551.40M | 25.52% |
| Dec 31, 2024 | 2.16B | -13.64M | -0.63% |
| Dec 31, 2023 | 2.17B | 218.94M | 11.20% |
| Dec 31, 2022 | 1.96B | 309.34M | 18.80% |
| Dec 31, 2021 | 1.65B | 259.78M | 18.74% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Pharscin Pharmaceutical | 827.14M |
| ChengDu ShengNuo Biotec | 801.40M |
| Luoxin Pharmaceuticals Group Stock | 2.37B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.04B |
| Guizhou Xinbang Pharmaceutical | 5.62B |
| Jinghua Pharmaceutical Group | 1.46B |
| Shanxi Zhendong Pharmaceutical Co.,Ltd | 2.78B |
| ChengDa Pharmaceuticals | 458.30M |